FDA Releases Draft Guidance for Combined Oncologic Drugs Advisory Committee Briefing Document

Summary

The FDA is releasing a draft guidance that combines the views of the FDA and sponsors on key issues for oncology products, aiming to provide efficiencies in the advisory committee process.